JESÚS PÉREZ LOSADA-rekin lankidetzan egindako argitalpenak (9)

2023

  1. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

2021

  1. Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma

    Cancers, Vol. 13, Núm. 20

  2. Viruses and skin cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 10

2019

  1. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 1, pp. 106-113.e2

2018

  1. Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma

    Clinical and Experimental Dermatology, Vol. 43, Núm. 8, pp. 876-882

2017

  1. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma

    British Journal of Dermatology, Vol. 176, Núm. 5, pp. 1279-1287

  2. MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma

    British Journal of Dermatology, Vol. 177, Núm. 1, pp. 168-178

  3. The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma

    Journal of Cutaneous Pathology, Vol. 44, Núm. 2, pp. 144-151

2013

  1. CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage

    British Journal of Dermatology, Vol. 169, Núm. 4, pp. 830-837